相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2018)
Adjustment of the GRACE score by 2-hour post-load glucose improves prediction of long-term major adverse cardiac events in acute coronary syndrome in patients without known diabetes
Sudipta Chattopadhyay et al.
EUROPEAN HEART JOURNAL (2018)
Myocardial infarction is sufficient to increase GLP-1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacity
Sebastian Diebold et al.
DIABETES OBESITY & METABOLISM (2018)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez et al.
LANCET (2018)
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score
Roland Klingenberg et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
Mark R. Thomas et al.
CIRCULATION RESEARCH (2017)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism
Corinna Lebherz et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemia
Sebastian Steven et al.
BASIC RESEARCH IN CARDIOLOGY (2015)
Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV-a survey from the European Society of Cardiology
Viveca Gyberg et al.
EUROPEAN HEART JOURNAL (2015)
Ly-6Chigh Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium
Ingo Hilgendorf et al.
CIRCULATION RESEARCH (2014)
GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6-Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering
Florian Kahles et al.
DIABETES (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cardioprotective Effects of Exenatide in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Results of Exenatide Myocardial Protection in Revascularization Study
Jong Shin Woo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
Paul Blanche et al.
STATISTICS IN MEDICINE (2013)
Exenatide Reduces Final Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction and Short-Duration of Ischemia
Jacob Lonborg et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
New antidiabetic therapies: innovative strategies for an old problem
Michael Lehrke et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
Jacob Lonborg et al.
EUROPEAN HEART JOURNAL (2012)
Myocardial infarction accelerates atherosclerosis
Partha Dutta et al.
NATURE (2012)
Plasma Interleukin-10 Levels and Adverse Outcomes in Acute Coronary Syndrome
Erdal Cavusoglu et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
Helga Ellingsgaard et al.
NATURE MEDICINE (2011)
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
Filip K. Swirski et al.
SCIENCE (2009)
Plasma NT-proBNP increases in response to LPS administration in healthy men
Greisa Vila et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart
Dwaine S. Burley et al.
BASIC RESEARCH IN CARDIOLOGY (2007)
Evaluating prediction rules for t-year survivors with censored regression models
Hajime Uno et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2007)
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
Keith A. A. Fox et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
The primary mechanism of the IL-10-regulated anti inflammatory response is to selectively inhibit transcription
PJ Murray
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:: a prospective study
A Norhammar et al.
LANCET (2002)
The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making
EM Antman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
